AstraZeneca vaccine needs "additional study"

London-ALSHARQIYA   November  27 : British pharmaceutical manufacturer AstraZeneca announced that more research is needed on the vaccine it develops to fight Covid-19, after questions emerged about the protection it could provide.
 The company's chief executive, Pascal Sorio, told Bloomberg that the results of the new international study may come out sooner and that the company is certain that the effectiveness of the vaccine is high, noting that these measures should not delay obtaining the approval of regulators in the European Union and the United Kingdom to circulate the vaccine.


Today, Saturday, a large number of Facebook users reported a problem with an application

English press reports revealed the rejection of the best duo in the world, Ronaldo and Messi

The Finance Committee in the Iraqi Council of Representatives continued to discuss proposals for a budget bill